Cargando…

Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives

Low-and-middle-income countries (LMICs) experience a high burden of cervical cancer. The human papillomavirus (HPV) vaccine prevents high-risk strains of HPV that cause cervical cancer; however, the integration of HPV vaccines into national immunization programs within many LMICs has been suboptimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Guillaume, Dominique, Waheed, Dur-e-Nayab, Schlieff, Meike, Muralidharan, Kirthini, Vorsters, Alex, Limaye, Rupali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766470/
https://www.ncbi.nlm.nih.gov/pubmed/36485172
http://dx.doi.org/10.1080/21645515.2022.2150454
_version_ 1784853737841360896
author Guillaume, Dominique
Waheed, Dur-e-Nayab
Schlieff, Meike
Muralidharan, Kirthini
Vorsters, Alex
Limaye, Rupali
author_facet Guillaume, Dominique
Waheed, Dur-e-Nayab
Schlieff, Meike
Muralidharan, Kirthini
Vorsters, Alex
Limaye, Rupali
author_sort Guillaume, Dominique
collection PubMed
description Low-and-middle-income countries (LMICs) experience a high burden of cervical cancer. The human papillomavirus (HPV) vaccine prevents high-risk strains of HPV that cause cervical cancer; however, the integration of HPV vaccines into national immunization programs within many LMICs has been suboptimal. Our study evaluated key factors that drive the decision-making process for the implementation of HPV vaccine programs in LMICs. Stakeholder analysis and semi-structured in-depth interviews were conducted with national and global stakeholders. Interview data were analyzed through qualitative descriptive methods. Findings from our study revealed the decision-making process for HPV vaccines requires the involvement of multiple institutions and stakeholders from national and global levels, with decision-making being a country-specific process. Partner considerations, locally driven processes, availability of data, and infrastructure and resource considerations were found to be critical factors in the decision-making process. Future programs should evaluate the best approaches for investing in initiatives to enhance coordination, ensure vaccine introduction is locally driven, increase the availability of data needed for decision-making, and equip countries with the necessary resources to guide country decision-making in the face of increasingly complex decision-making environments.
format Online
Article
Text
id pubmed-9766470
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-97664702022-12-21 Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives Guillaume, Dominique Waheed, Dur-e-Nayab Schlieff, Meike Muralidharan, Kirthini Vorsters, Alex Limaye, Rupali Hum Vaccin Immunother HPV – Research Article Low-and-middle-income countries (LMICs) experience a high burden of cervical cancer. The human papillomavirus (HPV) vaccine prevents high-risk strains of HPV that cause cervical cancer; however, the integration of HPV vaccines into national immunization programs within many LMICs has been suboptimal. Our study evaluated key factors that drive the decision-making process for the implementation of HPV vaccine programs in LMICs. Stakeholder analysis and semi-structured in-depth interviews were conducted with national and global stakeholders. Interview data were analyzed through qualitative descriptive methods. Findings from our study revealed the decision-making process for HPV vaccines requires the involvement of multiple institutions and stakeholders from national and global levels, with decision-making being a country-specific process. Partner considerations, locally driven processes, availability of data, and infrastructure and resource considerations were found to be critical factors in the decision-making process. Future programs should evaluate the best approaches for investing in initiatives to enhance coordination, ensure vaccine introduction is locally driven, increase the availability of data needed for decision-making, and equip countries with the necessary resources to guide country decision-making in the face of increasingly complex decision-making environments. Taylor & Francis 2022-12-09 /pmc/articles/PMC9766470/ /pubmed/36485172 http://dx.doi.org/10.1080/21645515.2022.2150454 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle HPV – Research Article
Guillaume, Dominique
Waheed, Dur-e-Nayab
Schlieff, Meike
Muralidharan, Kirthini
Vorsters, Alex
Limaye, Rupali
Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives
title Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives
title_full Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives
title_fullStr Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives
title_full_unstemmed Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives
title_short Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives
title_sort key decision-making factors for human papillomavirus (hpv) vaccine program introduction in low-and-middle-income-countries: global and national stakeholder perspectives
topic HPV – Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766470/
https://www.ncbi.nlm.nih.gov/pubmed/36485172
http://dx.doi.org/10.1080/21645515.2022.2150454
work_keys_str_mv AT guillaumedominique keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives
AT waheeddurenayab keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives
AT schlieffmeike keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives
AT muralidharankirthini keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives
AT vorstersalex keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives
AT limayerupali keydecisionmakingfactorsforhumanpapillomavirushpvvaccineprogramintroductioninlowandmiddleincomecountriesglobalandnationalstakeholderperspectives